These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 30821873)

  • 1. Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis.
    Kuk N; Hodge A; Sun Y; Correia J; Alhomrani M; Samuel C; Moore G; Lim R; Sievert W
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1441-1449. PubMed ID: 30821873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addressing the liver progenitor cell response and hepatic oxidative stress in experimental non-alcoholic fatty liver disease/non-alcoholic steatohepatitis using amniotic epithelial cells.
    Goonetilleke M; Kuk N; Correia J; Hodge A; Moore G; Gantier MP; Yeoh G; Sievert W; Lim R
    Stem Cell Res Ther; 2021 Jul; 12(1):429. PubMed ID: 34321089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
    Yamato M; Sakai Y; Mochida H; Kawaguchi K; Takamura M; Usui S; Seki A; Mizukoshi E; Yamashita T; Yamashita T; Ishida K; Nasti A; Tuyen HTB; Komura T; Yoshida K; Wada T; Honda M; Kaneko S
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1432-1440. PubMed ID: 30828861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl₄-treated mice.
    Manuelpillai U; Tchongue J; Lourensz D; Vaghjiani V; Samuel CS; Liu A; Williams ED; Sievert W
    Cell Transplant; 2010; 19(9):1157-68. PubMed ID: 20447339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Amnion Epithelial Cells Produce Soluble Factors that Enhance Liver Repair by Reducing Fibrosis While Maintaining Regeneration in a Model of Chronic Liver Injury.
    Hodge A; Andrewartha N; Lourensz D; Strauss R; Correia J; Goonetilleke M; Yeoh G; Lim R; Sievert W
    Cell Transplant; 2020; 29():963689720950221. PubMed ID: 32813573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.
    Manuelpillai U; Lourensz D; Vaghjiani V; Tchongue J; Lacey D; Tee JY; Murthi P; Chan J; Hodge A; Sievert W
    PLoS One; 2012; 7(6):e38631. PubMed ID: 22719909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thioacetamide potentiates high cholesterol and high fat diet induced steato-hepatitic changes in livers of C57BL/6J mice: A novel eight weeks model of fibrosing NASH.
    Sharma L; Gupta D; Abdullah ST
    Toxicol Lett; 2019 Apr; 304():21-29. PubMed ID: 30625377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice.
    Moore MP; Cunningham RP; Davis RAH; Deemer SE; Roberts BM; Plaisance EP; Rector RS
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G564-G572. PubMed ID: 33501889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A defect in endothelial autophagy occurs in patients with non-alcoholic steatohepatitis and promotes inflammation and fibrosis.
    Hammoutene A; Biquard L; Lasselin J; Kheloufi M; Tanguy M; Vion AC; Mérian J; Colnot N; Loyer X; Tedgui A; Codogno P; Lotersztajn S; Paradis V; Boulanger CM; Rautou PE
    J Hepatol; 2020 Mar; 72(3):528-538. PubMed ID: 31726115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.
    Kim KH; Kim SH; Han DH; Jo YS; Lee YH; Lee MS
    Sci Rep; 2018 May; 8(1):6789. PubMed ID: 29717162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of CC chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis.
    Morikawa R; Nakamoto N; Amiya T; Chu PS; Koda Y; Teratani T; Suzuki T; Kurebayashi Y; Ueno A; Taniki N; Miyamoto K; Yamaguchi A; Shiba S; Katayama T; Yoshida K; Takada Y; Ishihara R; Ebinuma H; Sakamoto M; Kanai T
    J Hepatol; 2021 Mar; 74(3):511-521. PubMed ID: 33038434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 is a key player in non-alcoholic steatohepatitis.
    Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
    J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human amnion epithelial cell transplantation abrogates lung fibrosis and augments repair.
    Moodley Y; Ilancheran S; Samuel C; Vaghjiani V; Atienza D; Williams ED; Jenkin G; Wallace E; Trounson A; Manuelpillai U
    Am J Respir Crit Care Med; 2010 Sep; 182(5):643-51. PubMed ID: 20522792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble factors derived from human amniotic epithelial cells suppress collagen production in human hepatic stellate cells.
    Hodge A; Lourensz D; Vaghjiani V; Nguyen H; Tchongue J; Wang B; Murthi P; Sievert W; Manuelpillai U
    Cytotherapy; 2014 Aug; 16(8):1132-44. PubMed ID: 24642017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.